High Times
Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

AVXL RSS Feed
Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, Steady_T, blanka, neiu, TomP1, Rubyred77
Search This Board: 
Last Post: 10/17/2018 7:55:25 PM - Followers: 717 - Board type: Free - Posts Today: 77

Anavex Life Sciences Corp (AVXL)



Company website:  http://www.anavex.com/
 
 Nasdaq 
 
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA
1-844-689-3939

 
CIK:  0001314052
 

Anavex®Life Sciences Corp. (the “Company”) is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer.  The Company’s lead compound ANAVEX®2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome.

Anavex®Life Sciences’ lead drug candidate, ANAVEX®2-73, recently completed successfully a Phase 2a clinical trial for Alzheimer’s disease.  ANAVEX®2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors.  Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. It has also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy and others.  The Michael J. Fox Foundation for Parkinson’s Research has awarded Anavex® a research grant to develop ANAVEX®2-73 for the treatment of Parkinson’s disease to fully fund a preclinical study, which could justify moving ANAVEX®2-73 into a Parkinson’s disease clinical trial.  ANAVEX®3-71, also targeting sigma-1 and M1 muscarinic receptors, is a promising preclinical drug candidate demonstrating disease modifications against the major Alzheimer’s hallmarks in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies, and also with beneficial effects on neuroinflammation and mitochondrial dysfunctions.

The Company is in preparation for ANAVEX®2-73 for a Phase 2/3, placebo-controlled trial in Alzheimer’s disease as well as a Phase 2, placebo-controlled trial in Rett syndrome, for which the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for ANAVEX®2-73 and a Phase 2, placebo-controlled trial in Parkinson’s disease.

Headquartered in New York, Anavex® Life Sciences is an American publicly traded corporation on Nasdaq quoted as AVXL

.
 
Management:   http://www.anavex.com/about-us/leadership/
 
Pipeline:  http://www.anavex.com/pipeline/

Patent Info: 
http://www.anavex.com/?s=patents

Clinical Trials:  https://clinicaltrials.gov/ct2/results?term=Anavex+Life+Sciences&Search=Search
 
Recent News:  http://finance.yahoo.com/q?s=avxl&ql=1
Company News Releases:  http://www.anavex.com/2015/?post_type=news
 
Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=anavex&owner=exclude&action=getcompany
 
Share Structure:  See SEC filings
 
Investor Relations:  ir@anavex.com

Marketing Details:  http://convention.bio.org/Printables/Anavex%20Life%20Sciences%20Corp..html

 



All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 
High Times
AVXL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXL News: Statement of Changes in Beneficial Ownership (4) 10/09/2018 04:44:17 PM
AVXL News: Statement of Changes in Beneficial Ownership (4) 10/03/2018 05:35:14 PM
AVXL News: Statement of Changes in Beneficial Ownership (4) 10/03/2018 05:34:22 PM
AVXL News: Statement of Changes in Beneficial Ownership (4) 10/03/2018 05:33:27 PM
AVXL News: Statement of Changes in Beneficial Ownership (4) 10/03/2018 05:32:35 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#168588  Sticky Note Notable posts - 10/17/18 XenaLives 10/17/18 11:27:10 AM
#166633  Sticky Note Thanks T... More to your post neiu 09/25/18 07:28:46 AM
#160507  Sticky Note here are a couple of those 32 from cninc 07/30/18 12:01:12 AM
#135567  Sticky Note Good lessons learned from AVXL investment in 2017. Rising_Sun 12/29/17 02:53:39 AM
#129044  Sticky Note People seem to always lose track of the dadofmarcmax 11/06/17 10:58:33 AM
#168622   Time to shut that manipulative angle down for tredenwater2 10/17/18 07:55:25 PM
#168621   And the crime beat goes on... so many basparks79 10/17/18 06:57:46 PM
#168620   I think I understand what needs to be understood. Investor2014 10/17/18 06:26:46 PM
#168619   2014, that is because those drugs do NOT powerwalker 10/17/18 06:24:53 PM
#168618   ... and we'll take a "PASS" on you, B***4! powerwalker 10/17/18 06:13:55 PM
#168617   Pitchforks for Authority that KNOWS the very limited McMagyar 10/17/18 05:26:59 PM
#168615   Curious. What if rock solid verifiable evidence showed nidan7500 10/17/18 04:55:33 PM
#168614   Like you optimism What is lacking in australia - Amatuer17 10/17/18 04:44:19 PM
#168613   Wow. Manipulating 2000 different stocks..... That is equal opportunity. Steady_T 10/17/18 04:14:23 PM
#168612   Thanks drv, if it was a snake it tredenwater2 10/17/18 03:20:18 PM
#168611   "It’s time for the pitchforks "--meaning ? explain plexrec 10/17/18 03:01:07 PM
#168610   Nice link Talon but really its not the tredenwater2 10/17/18 02:48:07 PM
#168609   Good one Rayo Huff post supports terror orgs McMagyar 10/17/18 02:36:36 PM
#168608   AVXL will not be pumped going into CTAD rayovacAAA 10/17/18 02:34:42 PM
#168607   Bio4....are you suggesting a conspiracy against Arianna afloat Talon38 10/17/18 02:29:47 PM
#168606   It’s time for the pitchforks McMagyar 10/17/18 02:29:34 PM
#168605   Thanks for posting. You have been missed. Kentucky123 10/17/18 02:27:15 PM
#168604   "He sees the share price virtually unchanged"--agree also---been plexrec 10/17/18 02:24:49 PM
#168603   The Huffington Post is a Pulitzer Prize-winning global rayovacAAA 10/17/18 02:20:54 PM
#168602   seeming incompetence of Anavex management and lack Investor2014 10/17/18 02:10:47 PM
#168600   Bio4....its incredulous that you would use the Huff Talon38 10/17/18 01:27:26 PM
#168599   So three years in.. And a quick read of McMagyar 10/17/18 01:21:55 PM
#168598   What is more dangerous? tradeherpete 10/17/18 01:14:17 PM
#168596   He is not a shareholder CEO. rayovacAAA 10/17/18 12:58:41 PM
#168595   He's getting a haircut right now. Later he rayovacAAA 10/17/18 12:55:09 PM
#168594   JJ The Cerebral Dr. is NOT the guy mrplmer 10/17/18 12:53:08 PM
#168593   Does Missling care about share price? Jonjones325 10/17/18 12:25:23 PM
#168592   The share price of Anavex will prosper greatly bennyboy1 10/17/18 12:09:43 PM
#168591   Lots of drugs are deemed to work in Investor2014 10/17/18 12:07:23 PM
#168590   Any reasonable person will agree Anavex works, or bennyboy1 10/17/18 12:03:11 PM
#168589   Yes Tred, he is the presenter of a drv17 10/17/18 12:02:09 PM
#168588   Notable posts - 10/17/18 XenaLives 10/17/18 11:27:10 AM
#168587   Also coincidental that the research is from Spain. Investor2014 10/17/18 11:20:21 AM
#168586   Thanks for sharing that article. Very interesting. Steady_T 10/17/18 11:16:07 AM
#168585   https://www.eurekalert.org/pub_releases/2018-10/uoe-nbf100918.php New biomarker for A Investor2014 10/17/18 10:59:47 AM
#168584   Or Bio4. Investor2014 10/17/18 10:29:45 AM
#168582   You should ask Fred Knoll or Park West... basparks79 10/17/18 10:20:57 AM
#168581   Once again Neuren is just about the worst Investor2014 10/17/18 10:20:06 AM
#168579   "Kentucky-Plex-Investor-good feedback."--thanks nidan---we're on the same team- plexrec 10/17/18 10:14:17 AM
#168578   Vtvt is closely held, may be a P&D... XenaLives 10/17/18 10:05:46 AM
#168577   I would like to know which "world class" investors LakeshoreLeo1953 10/17/18 09:59:44 AM
#168576   There is certainly EVIDENCE that trial patients have basparks79 10/17/18 09:56:49 AM
#168574   There is always more interest in biotechs that basparks79 10/17/18 09:50:30 AM
#168573   And please could you add how long investors Investor2014 10/17/18 09:47:17 AM
#168572   Kentucky-Plex-Investor-good feedback. No debate w/any comments. The numbers nidan7500 10/17/18 09:46:31 AM
#168571   Plex, you're right in looking for any shred riaguy 10/17/18 09:46:18 AM
#168570   Try this one... XenaLives 10/17/18 09:45:54 AM
#168569   You've got to be kidding! Trofinetide Rett basparks79 10/17/18 09:45:39 AM
#168568   I doubt it. Their AD drug failed on Investor2014 10/17/18 09:44:50 AM
#168567   Opinion stated as fact... XenaLives 10/17/18 09:40:05 AM
PostSubject